So were spending more money to acquire a diagnostic supposedly inferior to Lympro with no top line data let alone revenue....i hope Gerald didnt really take a binus for "launching"
Im not saying the sky is falling but getting lympro data from July to now has been nothing short of a circus show a true debacle.
(0)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links